This cluster of papers focuses on the global impact of counterfeit drugs, particularly in the context of antimalarial and other essential medicines. It addresses the public health risks, pharmaceutical counterfeiting, medicine adulteration, and the development of detection technologies to combat the proliferation of counterfeit drugs. The cluster also discusses the challenges associated with online pharmacies and emphasizes the importance of ensuring drug quality for patient safety.